Acute Endocrine and Metabolic Complications During Treatment in Childhood Acute Lymphoblastic Leukemia Patients: Retrospective Study

被引:0
|
作者
Evim, Melike Sezgin [1 ]
Tobcu, Zeynep [2 ]
Guler, Salih [1 ]
Ongen, Yasemin Denkboy [3 ]
Gunes, Adalet Meral [1 ]
机构
[1] Uludag Univ, Cocuk Sagligi & Hastaliklari Anabilim Dali, Cocuk Hematoloji Bilim Dali, Tip Fak, Bursa, Turkiye
[2] Uludag Univ, Cocuk Sagligi & Hastaliklari Anabilim Dali, Tip Fak, Bursa, Turkiye
[3] Uludag Univ, Cocuk Sagligi & Hastaliklari Anabilim Dali, Cocuk Endokrinol Bilim Dali, Tip Fak, Bursa, Turkiye
来源
GUNCEL PEDIATRI-JOURNAL OF CURRENT PEDIATRICS | 2023年 / 21卷 / 01期
关键词
Pediatric ALL; endocrine complication; chemotherapy; RISK-FACTORS; CHILDREN; SURVIVORS; CANCER; HYPERGLYCEMIA; HYPOGLYCEMIA;
D O I
10.4274/jcp.2022.76258
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction: Acute leukemias are the most common malignancy of childhood, and acute lymphoblastic leukemia (ALL) is the most common subtype. In this study; we aimed to asses to acute endocrine and metabolic complications which occurs during treatment. Newly diagnosed ALL patients were included in the study. Materials and Methods: The endocrine and metabolic complication of 293 patients aged 1-18 years old who were newly diagnosed ALL between January 2007 and December 2017 in Uludag University Faculty, Department of Pediatric Hematology were analyzed. Patients' age, gender, risk groups, leukemia subtypes, and chemotherapy phases at the time of endocrine complications were noted. Results: In total, 250 patients were follow-up with B-ALL and 43 patients with T-ALL. 64% (n=188) of patients were male and 36% (n=105) were female. In our study, 36.4% of patients were in the high risk group but ten of the patients died before the risk group could be determined. During the two-year treatment, We found that 83% of the patients developed at least one endocrine complication. Hyperglycemia, osteoporosis and avascular necrosis were observed more frequently in patients older than 10 years at the time of diagnosis. The difference between the sexes was found only in vitamin D and was lower in girls. In regression analysis, only to be high risk group were found to be effective for the development of endocrine complications. Conclusion: Although the chemotherapeutics used today have prolonged the survival time, they have caused an increase in the incidence of complications. We think that these complications can be reduced by determining the risk factors in advance.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [1] Endocrine complications in pediatric patients with acute lymphoblastic leukemia
    Howard, SC
    Pui, CH
    BLOOD REVIEWS, 2002, 16 (04) : 225 - 243
  • [2] EVALUATION OF ENDOCRINE LATE COMPLICATIONS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA SURVIVORS
    Bayram, C.
    Yarali, N.
    Fettah, A.
    Demirel, F.
    Kara, A.
    Tunc, B.
    HAEMATOLOGICA, 2015, 100 : 645 - 645
  • [3] Infection-related complications during treatment for childhood acute lymphoblastic leukemia
    Inaba, H.
    Pei, D.
    Wolf, J.
    Howard, S. C.
    Hayden, R. T.
    Go, M.
    Varechtchouk, O.
    Hahn, T.
    Buaboonnam, J.
    Metzger, M. L.
    Rubnitz, J. E.
    Ribeiro, R. C.
    Sandlund, J. T.
    Jeha, S.
    Cheng, C.
    Evans, W. E.
    Relling, M. V.
    Pui, C. -H.
    ANNALS OF ONCOLOGY, 2017, 28 (02) : 386 - 392
  • [4] Metabolic Fingerprint in Childhood Acute Lymphoblastic Leukemia
    Papadopoulou, Maria T.
    Panagopoulou, Paraskevi
    Paramera, Efstathia
    Pechlivanis, Alexandros
    Virgiliou, Christina
    Papakonstantinou, Eugenia
    Palabougiouki, Maria
    Ioannidou, Maria
    Vasileiou, Eleni
    Tragiannidis, Athanasios
    Papakonstantinou, Evangelos
    Theodoridis, Georgios
    Hatzipantelis, Emmanuel
    Evangeliou, Athanasios
    DIAGNOSTICS, 2024, 14 (07)
  • [5] Metabolic reprogramming in childhood acute lymphoblastic leukemia
    Sbirkov, Yordan
    Burnusuzov, Hasan
    Sarafian, Victoria
    PEDIATRIC BLOOD & CANCER, 2020, 67 (06)
  • [6] Treatment of Childhood Acute Lymphoblastic Leukemia
    Stanulla, Martin
    Schrappe, Martin
    SEMINARS IN HEMATOLOGY, 2009, 46 (01) : 52 - 63
  • [7] Treatment of Acute Lymphoblastic Leukemia in Childhood
    Schrappe, Martin
    ANNALS OF HEMATOLOGY, 2017, 96 : S35 - S36
  • [8] ACUTE METABOLIC SIDE EFFECTS OF REMISSION INDUCTION TREATMENT IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
    Aydogan, M.
    Atasoy, F.
    Tugcu, D.
    Akici, F.
    Salcioglu, Z.
    Akcay, A.
    Sen, H.
    Demirkaya, M.
    Ayaz, N.
    HAEMATOLOGICA, 2012, 97 : 494 - 494
  • [9] Metabolic Complications During Induction Therapy in Children with Acute Lymphoblastic Leukemia
    Echebarria, A.
    Garcia, N.
    De Pedro, J.
    Gonzalez, U.
    Garcia-Obregon, S.
    Capape, S.
    Adan, R.
    Lopez-Almaraz, R.
    Garcia-Ariza, M.
    Grau, G.
    Portillo, N.
    Rica, I.
    Martin, I.
    Garcia-Orad, A.
    Astigarraga, I.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S104 - S105
  • [10] Study of metabolic complications in young adults treated for acute lymphoblastic leukemia or non-Hodgkinian lymphoma during childhood
    Steffens, M.
    Beauloye, V.
    Brichard, B.
    Vermylen, C.
    Maiter, D.
    DIABETES & METABOLISM, 2008, 34 : A11 - A12